Tag: Europe

Wegovy received marketing authorization valid throughout the European Union on January 6, 2022, following a positive assessment by the European Medicines Agency (EMA). Despite this blanket approval, the question "**Is Wegovy banned in Europe for weight loss?**" frequently arises due to significant variations in national launches, reimbursement policies, and persistent supply challenges across the continent.

Approximately one-third of people with depression do not respond to initial antidepressant medications, highlighting a critical need for new treatments. The latest wave of **new antidepressants in Europe** focuses on novel mechanisms to address this unmet need, moving beyond the traditional serotonin and norepinephrine pathways to offer faster and more effective options, particularly for difficult-to-treat cases.

With a trusted history of over a century, Tiger Balm is a widely used herbal ointment for pain relief [1.2.1]. If you're wondering, **can you buy Tiger Balm in Europe?** The answer is yes, through a variety of accessible channels.

In 2011, the pharmaceutical company Takeda voluntarily withdrew its serrapeptase product in Japan after postmarketing trials found it ineffective for its approved uses [1.7.3, 1.6.1]. This event casts a long shadow over the question: is serrapeptase banned in Europe?

Between 1973 and 1980, around 1,000 cases of bismuth-related neurotoxicity were reported in France alone, leading to a significant shift in regulatory attitudes. This historical context is key to understanding **why is Pepto-Bismol banned in Europe**, or at least heavily restricted, unlike its over-the-counter status in the U.S.

According to the European Medicines Agency (EMA), several effective non-statin medications are approved for patients with high cholesterol. These therapies provide vital alternatives for individuals unable to tolerate statins or who require further low-density lipoprotein cholesterol (LDL-C) reduction. The question of **what does Europe use instead of statins** reveals a landscape of modern pharmaceutical options complementing or replacing traditional statin use.